Mar 31, 2026 07:06AM
Mar 31, 2026 06:40AM
Mar 31, 2026 06:40AM
May 17, 2023 11:45AM
Mar 23, 2023 02:30AM
Mar 7, 2023 01:30AM
Feb 15, 2023 12:24PM Poxel Reports Cash and Revenue for the Full Year 2022 and Provides Corporate Update
Jan 25, 2023 01:30AM
Nov 8, 2022 11:45AM
Nov 7, 2022 02:15PM
Oct 12, 2022 01:30AM
Oct 3, 2022 01:30AM
Sep 21, 2022 01:30AM
Sep 21, 2022 01:30AM Poxel Announces Positive Histology Results from Phase 2 NASH Trial (DESTINY-1) for PXL065, a Novel, Proprietary Deuterium-Stabilized R-stereoisomer of Pioglitazone
Aug 30, 2022 01:30AM
Aug 8, 2022 01:00AM
May 17, 2022 12:29PM
May 17, 2022 11:45AM
Apr 11, 2022 11:45AM
Mar 22, 2022 01:06PM
Feb 16, 2022 11:45AM Poxel Reports Financial Update for Cash and Revenue for the Full Year 2021 and Provides Corporate Update
Feb 16, 2022 11:45AM
Sep 21, 2021 01:00AM
Apr 21, 2021 11:45AM
Mar 24, 2021 12:45PM
Feb 12, 2021 01:30AM
Jan 14, 2021 11:45AM
Nov 30, 2020 11:45AM Poxel to Host Virtual NASH Investor Event with Leading Experts on December 14, 2020
Nov 16, 2020 11:45AM
Nov 9, 2020 11:45AM
Oct 20, 2020 11:45AM
Sep 15, 2020 11:35AM
Sep 2, 2020 02:00AM
Jul 21, 2020 11:45AM
Apr 21, 2020 11:45AM Poxel Announces First Quarter 2020 Financial and Corporate Update
Apr 20, 2020 02:00AM
Mar 26, 2020 12:40PM
Feb 12, 2020 11:45AM
Dec 18, 2019 02:00AM
Nov 12, 2019 02:00AM
Nov 8, 2019 02:00AM
Nov 7, 2019 11:45AM Poxel to Present Results From Phase 1a Study of PXL065 at the Liver Meeting® 2019
Nov 5, 2019 02:00AM
Oct 7, 2019 11:45AM
Sep 17, 2019 02:00AM
Aug 26, 2019 11:45AM
Jul 15, 2019 02:00AM
Nov 26, 2018 02:00AM
Jul 18, 2018 02:00AM Poxel Announces Favorable Results for PXL770 Phase 1b Multiple Ascending Dose Trial and Drug-Drug Interaction Study

323,590 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All